ARL6IP4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.405800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.537200E-01
Normal-vs-Stage2
3.895800E-01
Normal-vs-Stage3
4.624400E-01
Normal-vs-Stage4
2.370400E-01
Stage1-vs-Stage2
4.126000E-01
Stage1-vs-Stage3
4.521600E-01
Stage1-vs-Stage4
4.175600E-01
Stage2-vs-Stage3
7.130800E-01
Stage2-vs-Stage4
9.952200E-01
Stage3-vs-Stage4
8.081600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.855800E-01
Normal-vs-AfricanAmerican
1.917360E-01
Normal-vs-Asian
6.386200E-01
Caucasian-vs-AfricanAmerican
4.198400E-01
Caucasian-vs-Asian
9.220600E-01
AfricanAmerican-vs-Asian
4.766200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.978000E-01
Normal-vs-Female
6.922600E-01
Male-vs-Female
7.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.660600E-01
Normal-vs-Age(41-60Yrs)
5.067800E-01
Normal-vs-Age(61-80Yrs)
5.415800E-01
Normal-vs-Age(81-100Yrs)
7.082800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.835000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.709200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.271000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.231000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.689800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.224300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.213000E-01
Normal-vs-Daily Drinker
7.081400E-01
Normal-vs-Weekly Drinker
9.223700E-02
Normal-vs-Occasional Drinker
8.475400E-01
Normal-vs-Social Drinker
3.346800E-01
Non Drinker-vs-Daily Drinker
6.002400E-02
Non Drinker-vs-Weekly Drinker
7.477000E-01
Non Drinker-vs-Occasional Drinker
4.299000E-01
Non Drinker-vs-Social Drinker
7.057000E-01
Daily Drinker-vs-Weekly Drinker
2.736300E-02
Daily Drinker-vs-Occasional Drinker
2.817200E-01
Daily Drinker-vs-Social Drinker
3.730400E-02
Weekly Drinker-vs-Occasional Drinker
2.752800E-01
Weekly Drinker-vs-Social Drinker
8.474200E-01
Occasional Drinker-vs-Social Drinker
3.064400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.762400E-01
Normal-vs-Grade 2
4.815600E-01
Normal-vs-Grade 3
5.587800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.641700E-02
Grade 1-vs-Grade 3
1.081430E-01
Grade 1-vs-Grade 4
4.762400E-01
Grade 2-vs-Grade 3
8.058000E-01
Grade 2-vs-Grade 4
4.815600E-01
Grade 3-vs-Grade 4
5.587800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.480600E-01
Normal-vs-NonDiabetic
7.856800E-01
Diabetic-vs-NonDiabetic
6.164600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.335200E-01
Normal-vs-NoPancreatitis
6.977800E-01
Pancreatitis-vs-NoPancreatitis
6.883400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.807600E-01
Normal-vs-N1
3.819600E-01
N0-vs-N1
5.950000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.811800E-01
Normal-vs-TP53-NonMutant
8.744600E-01
TP53-Mutant-vs-TP53-NonMutant
2.141400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
